Home  |   Contact Us  |   Site Map  |  Search     
Hans Keirstead's Research

Hans Keirstead's Research

The focus of the Keirstead Laboratory at UC Irvine is the development of strategies to limit degeneration and enhance regeneration after spinal cord injury and disease. The Keirstead Research Group utilizes a broad number of investigative techniques, including molecular and histological analyses, complex tissue culture, and in vivo experimentation. The Keirstead Research Group is also staffed to engage in FDA compliant pre-clinical work, employing a Regulatory Quality Assurance team that ensures that all research is FDA compliant.

The Keirstead Research Group is investigating strategies to reduce or eliminate the post traumatic enlargement of spinal cord injury sites that normally occurs after traumatic injury. The team developed an injection-based therapy that significantly decreased tissue loss if administered soon after injury. Human reagents necessary for clinical trials have been generated, and a clinical trial using this approach began in late-2005.

The Keirstead Research Group also investigates cell transplantation therapy for spinal cord injury, and was the first laboratory in North America to gain access to human embryonic stem cells

Embryonic Stem Cells
Stem Cells
Undifferentiated cells,
Undifferentiated Cells
Cells that can become other cell types. They have not yet decided their fate; what type of cell they will become.
that can give rise to more mature differentiated cells and have the ability to self-replicate. There are many kinds of stem cells – adult stem cells (AS), embryonic cells (ES), embryonic germ cells (EG).
Pluripotent
Pluripotent Stem-Cells
Stem cells, which can develop into any of the three major tissue types: endoderm (interior gut lining), mesoderm (muscle, bone, blood), and ectoderm (epidermal tissues and nervous system). Pluripotent stem cells can eventually specialize in any bodily tissue, but they cannot themselves develop into a human being.
cells that can differentiate into various tissues in the body.
(hESCs)
hESCs
Human embryonic stem cells.
for CNS trauma research. The team is generating new hESC
hESC
Human embryonic stem cells.
lines from blastocysts
Blastocysts
A preimplantation embryo
Embryo
Organisms in the early stages of growth and development. In human, “embryo” generally refers to the time from implantation to about eight to twelve weeks after conception.
of about 150 cells produced by cell division following fertilization. The blastocyst is a sphere made up of an outer layer of cells (the trophoblast), a fluid-filled cavity (the blastocoel), and a cluster of cells on the interior (the inner cell mass).
and using somatic cell nuclear transfer (SCNT)
SCNT
Somatic Cell Nuclear Transfer (or Therapeutic cloning) - process of transferring a somatic cell into an enucleated cell.
, and developing protocols to differentiate hESCs into high purity populations of human cells. For example, the team developed high purity hESC-derived oligodendrocyte progenitors with the goal of treating demyelination in acute spinal cord injury, and investigating the development of this human lineage. This work is the basis of a therapy that is currently being developed for clinical trials. The laboratory is generating other cell populations that may benefit chronic spinal cord injury and other diseases of the spinal cord, and is also researching means to eliminate the glial scar that forms after spinal cord injury and multiple sclerosis.